FARMINGDALE, N.Y., Feb. 11 /PRNewswire-FirstCall/ -- Misonix, Inc. , a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced plans to release second quarter ended December 31, 2009 financial results on Tuesday afternoon, February 16, 2010. Michael A. McManus, President and Chief Executive Officer and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call at 4:30 p.m. Eastern on Tuesday, February 16, 2010 to discuss the Company's second quarter 2010 financial results.
A recording of the live-call will be available approximately 2 hours after the event through February 23, 2010. The dial-in number to listen to the recording is (888) 286 8010 or (617) 801 6888. The replay access code is 15380068.
Misonix, Inc.
